Global Brain Implant Market

Global Brain Implant Market Size, Share, Growth Analysis, By Type(Deep brain stimulation (DBS) and vagus nerve stimulation (VNS).), By Application(Parkinson's disease, epilepsy), By End user(Hospitals, neurology clinics) - Industry Forecast 2024-2031

Report ID: SQMIG45A2172 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 88 | Figures: 76

To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
$5,300
BUY NOW
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Brain Implant Market size was valued at USD 1.25 billion in 2021 and is poised to grow from USD 1.4 billion in 2022 to USD 3.52 billion by 2030, at a CAGR of 12.2% during the forecast period (2023-2030).

The competitive landscape of the global brain implant market is characterized by intense competition among key players striving to innovate and capture market share. These companies invest heavily in research and development to introduce technologically advanced brain implant devices and expand their product portfolios. Collaborations, partnerships, and acquisitions are common strategies employed by these players to strengthen their market presence. 'Medtronic (United States)', 'Abbott Laboratories (United States)', 'Boston Scientific Corporation (United States)', 'NeuroPace (United States)', 'Cochlear Limited (Australia)', 'LivaNova PLC (United Kingdom)', 'Stryker Corporation (United States)', 'Nevro Corporation (United States)', 'NDI Medical (United States)', 'Nihon Kohden Corporation (Japan)', 'Second Sight Medical Products, Inc. (United States)', 'Aleva Neurotherapeutics SA (Switzerland)', 'Renishaw plc (United Kingdom)', 'Cyberonics, Inc. (United States)', 'Neuronetics, Inc. (United States)', 'Natus Medical Incorporated (United States)', 'BrainLab AG (Germany)', 'St. Jude Medical, Inc. (United States)', 'NeuroSigma, Inc. (United States)', 'Alpha Omega Engineering (Israel)'

The rising incidence and prevalence of neurological disorders such as Parkinson's disease, epilepsy, and chronic pain are driving the demand for brain implant technologies. These implants offer effective treatment options for managing symptoms and improving patients' quality of life.

One key market trend in the global brain implant market is the increasing focus on miniaturization and wireless connectivity of implantable devices. Advancements in technology have led to the development of smaller, more compact brain implants, reducing the invasiveness of surgical procedures and enhancing patient comfort. Miniaturized implants offer the potential for minimally invasive or even non-invasive approaches, such as transcranial magnetic stimulation (TMS) or non-invasive electrical stimulation techniques. These advancements are particularly important for patients who may benefit from long-term implantation, as smaller devices can reduce the risk of complications and allow for easier implantation and removal.

Among these, North America stands out as the dominating region, while Asia-Pacific is identified as the fastest-growing region. North America, including the United States, Canada, and Mexico, holds a significant market share in the global brain implant market . The region benefits from advanced healthcare infrastructure, robust research and development activities, and a high prevalence of neurological disorders. The United States, in particular, has a strong presence of key market players and renowned research institutions, contributing to the region's dominance. For instance, Medtronic, a leading medical device company, holds a significant share in the brain implant market and is headquartered in Minnesota, USA. The region's focus on technological advancements, regulatory support, and reimbursement policies further propels the market growth.

Related Reports

Global Internet of Things (IoT) Professional Service Market
Buy Now GET FREE SAMPLE
Wealth Management Platform Market
Buy Now GET FREE SAMPLE
Global Travel Management Software Market
Buy Now GET FREE SAMPLE
Global Club Management Software Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Brain Implant Market

Product ID: SQMIG45A2172

$5,300
BUY NOW